Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wiman

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|December 30, 1998
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosisM T Sartori, B Wiman, S Vettore, et al.
Atherosclerosis|December 2, 1999
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in StockholmC Held, P Hjemdahl, N Håkan Wallén, et al.
European Journal of Biochemistry|August 3, 1987
Amino-acid sequence of human alpha 2-antiplasminH R Lijnen, W E Holmes, B van Hoef, et al.
British Heart Journal|January 1, 1986
Haemostatic function in myocardial infarctionA Hamsten, M Blombäck, B Wiman, et al.
European Heart Journal|May 6, 1998
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic functionP Båvenholm, U de Faire, C Landou, et al.
Anticancer Research|January 12, 2000
Angiostatin fragments in urine from patients with malignant diseaseM Sten-Linder, C Linder, H Strander, et al.
Journal of Internal Medicine|January 24, 2007
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentrationM N Mannila, P Eriksson, K Leander, et al.
Thrombosis and Haemostasis|August 26, 1998
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass graftingE Moor, A Silveira, F van't Hooft, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Journal of Internal Medicine|January 1, 1997
Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controlsC Held, P Hjemdahl, N Rehnqvist, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|December 30, 1998
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosisM T Sartori, B Wiman, S Vettore, et al.
Atherosclerosis|December 2, 1999
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in StockholmC Held, P Hjemdahl, N Håkan Wallén, et al.
European Journal of Biochemistry|August 3, 1987
Amino-acid sequence of human alpha 2-antiplasminH R Lijnen, W E Holmes, B van Hoef, et al.
British Heart Journal|January 1, 1986
Haemostatic function in myocardial infarctionA Hamsten, M Blombäck, B Wiman, et al.
European Heart Journal|May 6, 1998
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic functionP Båvenholm, U de Faire, C Landou, et al.
Anticancer Research|January 12, 2000
Angiostatin fragments in urine from patients with malignant diseaseM Sten-Linder, C Linder, H Strander, et al.
Journal of Internal Medicine|January 24, 2007
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentrationM N Mannila, P Eriksson, K Leander, et al.
Thrombosis and Haemostasis|August 26, 1998
Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass graftingE Moor, A Silveira, F van't Hooft, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Journal of Internal Medicine|January 1, 1997
Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controlsC Held, P Hjemdahl, N Rehnqvist, et al.
Pageof 13